644 related articles for article (PubMed ID: 15851640)
1. Microbiologic determinants of exacerbation in chronic obstructive pulmonary disease.
Rosell A; Monsó E; Soler N; Torres F; Angrill J; Riise G; Zalacaín R; Morera J; Torres A
Arch Intern Med; 2005 Apr; 165(8):891-7. PubMed ID: 15851640
[TBL] [Abstract][Full Text] [Related]
2. Sputum bacteriology in hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease in Taiwan with an emphasis on Klebsiella pneumoniae and Pseudomonas aeruginosa.
Lin SH; Kuo PH; Hsueh PR; Yang PC; Kuo SH
Respirology; 2007 Jan; 12(1):81-7. PubMed ID: 17207030
[TBL] [Abstract][Full Text] [Related]
3. Yield of sputum microbiological examination in patients hospitalized for exacerbations of chronic obstructive pulmonary disease with purulent sputum.
Roche N; Kouassi B; Rabbat A; Mounedji A; Lorut C; Huchon G
Respiration; 2007; 74(1):19-25. PubMed ID: 16675894
[TBL] [Abstract][Full Text] [Related]
4. [A clinical study of bacterial infection in patients with chronic obstructive pulmonary disease].
Zhao M; Gu G; Liu Z; Zhang X; Xu W; Fang Q
Zhonghua Jie He He Hu Xi Za Zhi; 1999 Feb; 22(2):88-91. PubMed ID: 11820948
[TBL] [Abstract][Full Text] [Related]
5. Multiple-drug-resistant bacteria in patients with severe acute exacerbation of chronic obstructive pulmonary disease: Prevalence, risk factors, and outcome.
Nseir S; Di Pompeo C; Cavestri B; Jozefowicz E; Nyunga M; Soubrier S; Roussel-Delvallez M; Saulnier F; Mathieu D; Durocher A
Crit Care Med; 2006 Dec; 34(12):2959-66. PubMed ID: 17012911
[TBL] [Abstract][Full Text] [Related]
6. A prediction model for bacterial etiology in acute exacerbations of COPD.
Lode H; Allewelt M; Balk S; De Roux A; Mauch H; Niederman M; Schmidt-Ioanas M
Infection; 2007 Jun; 35(3):143-9. PubMed ID: 17565454
[TBL] [Abstract][Full Text] [Related]
7. [Pseudomonas aeruginosa in chronic obstructive pulmonary disease].
Wavre-Oberhänsli A; Nicod LP
Rev Med Suisse; 2010 Nov; 6(272):2240-3. PubMed ID: 21207736
[TBL] [Abstract][Full Text] [Related]
8. Bronchoscopic validation of the significance of sputum purulence in severe exacerbations of chronic obstructive pulmonary disease.
Soler N; Agustí C; Angrill J; Puig De la Bellacasa J; Torres A
Thorax; 2007 Jan; 62(1):29-35. PubMed ID: 16928715
[TBL] [Abstract][Full Text] [Related]
9. Bacterial infection and risk factors in outpatients with acute exacerbation of chronic obstructive pulmonary disease: a 2-year prospective study.
Alamoudi OS
Respirology; 2007 Mar; 12(2):283-7. PubMed ID: 17298464
[TBL] [Abstract][Full Text] [Related]
10. Patients with chronic obstructive pulmonary disease and chronically colonized with Haemophilus influenzae during stable disease phase have increased airway inflammation.
Tufvesson E; Bjermer L; Ekberg M
Int J Chron Obstruct Pulmon Dis; 2015; 10():881-9. PubMed ID: 26005341
[TBL] [Abstract][Full Text] [Related]
11. Predictors of positive sputum cultures in exacerbations of chronic obstructive pulmonary disease.
Tsimogianni AM; Papiris SA; Kanavaki S; Stathopoulos GT; Sotiropoulou C; Manali ED; Michalopoulou P; Roussos C; Kotanidou A
Respirology; 2009 Nov; 14(8):1114-20. PubMed ID: 19761538
[TBL] [Abstract][Full Text] [Related]
12. Bacterial colonisation of lower airways in health and chronic lung disease.
Weinreich UM; Korsgaard J
Clin Respir J; 2008 Apr; 2(2):116-22. PubMed ID: 20298316
[TBL] [Abstract][Full Text] [Related]
13. Exacerbations of chronic obstructive pulmonary disease.
Wedzicha JA; Donaldson GC
Respir Care; 2003 Dec; 48(12):1204-13; discussion 1213-5. PubMed ID: 14651761
[TBL] [Abstract][Full Text] [Related]
14. New strains of bacteria and exacerbations of chronic obstructive pulmonary disease.
Sethi S; Evans N; Grant BJ; Murphy TF
N Engl J Med; 2002 Aug; 347(7):465-71. PubMed ID: 12181400
[TBL] [Abstract][Full Text] [Related]
15. Pseudomonas aeruginosa and mortality after hospital admission for chronic obstructive pulmonary disease.
Almagro P; Salvadó M; Garcia-Vidal C; Rodríguez-Carballeira M; Cuchi E; Torres J; Heredia JL
Respiration; 2012; 84(1):36-43. PubMed ID: 21996555
[TBL] [Abstract][Full Text] [Related]
16. [The role of macrolides in treatment of exacerbations of chronic obstructive pulmonary disease].
Targowski T; Jahnz-Rózyk K
Pol Merkur Lekarski; 2010 Apr; 28(166):311-4. PubMed ID: 20491344
[TBL] [Abstract][Full Text] [Related]
17. Persistent colonization by Haemophilus influenzae in chronic obstructive pulmonary disease.
Murphy TF; Brauer AL; Schiffmacher AT; Sethi S
Am J Respir Crit Care Med; 2004 Aug; 170(3):266-72. PubMed ID: 15117742
[TBL] [Abstract][Full Text] [Related]
18. Colour of sputum is a marker for bacterial colonisation in chronic obstructive pulmonary disease.
Miravitlles M; Marín A; Monsó E; Vilà S; de la Roza C; Hervás R; Esquinas C; García M; Millares L; Morera J; Torres A
Respir Res; 2010 May; 11(1):58. PubMed ID: 20470372
[TBL] [Abstract][Full Text] [Related]
19. Sputum bacteriology in patients with acute exacerbations of COPD in Hong Kong.
Ko FW; Ng TK; Li TS; Fok JP; Chan MC; Wu AK; Hui DS
Respir Med; 2005 Apr; 99(4):454-60. PubMed ID: 15763452
[TBL] [Abstract][Full Text] [Related]
20. Tobramycin Nebulizer Solution in severe COPD patients colonized with Pseudomonas aeruginosa: effects on bronchial inflammation.
Dal Negro R; Micheletto C; Tognella S; Visconti M; Turati C
Adv Ther; 2008 Oct; 25(10):1019-30. PubMed ID: 18821068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
